Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: J Neurosci. 2012 Aug 1;32(31):10541–10553. doi: 10.1523/JNEUROSCI.0767-12.2012

Table 2.

Details of hemispheres included in the analysis. The numbers of trials refer to the movement with the contralateral hand.

Case Side Selected
STN
channel		 Dominant
hemisphere		 Numbers of trials (M1 power/STN power/Coherence) MNI coordinates of
M1 source		 Footnotes
SYN OFF SEQ OFF SYN ON SEQ ON
1 left L23 no 30/31/32 14/14/14 14/15/16 15/15/15 −46 −22 56 f
1 right R23 yes 24/23/24 23/22/24 15/16/16 14/14/16 40 −8 58
2 left L12 yes 16/14/16 12/12/13 24/23/24 12/12/12 −24 −28 48
2 right R12 no 13/13/14 13/16/16 17/10/17 14/7/16 16 −2 68
3 left L23 yes - - −/15/15 −/6/6 −56 −10 44 a, d
3 right R12 no - - −/13/13 −/13/13 44 0 52 a, d
4 right R23 no 9/16/16 21/24/24 - - 30 −10 40 b
5 left L23 yes −/21/21 −/16/16 −/15/16 −/15/16 −36 −2 46 d, e1
5 right R23 no −/19/20 −/15/16 −/16/16 −/15/16 36 12 56 d, e2, f
6 left L23 yes - - 15/13/16 22/22/23 −34 −10 44 a
6 right R23 no - - 16/16/16 16/14/16 28 −8 72 a
7 left L01 yes 14/15/16 16/15/16 14/13/15 15/16/16 −32 −38 52
7 right R12 no 16/16/16 12/12/12 15/9/15 16/4/16 50 −38 48
8 left L23 yes 15/14/15 16/16/16 14/14/15 16/16/16 −40 −12 54
8 right R23 no 16/16/16 15/14/16 8/13/14 14/16/16 42 −6 58
9 left L23 yes 12/15/16 11/14/16 15/16/16 16/16/16 −30 −8 60
9 right R23 no 8/16/16 3/16/16 14/14/16 13/20/20 50 −36 46
10 left L12 yes - - 19/15/23 19/16/24 −36 −10 60 a, f
10 right R12 no - - −/15/24 −/14/16 34 −4 62 a, d, f
11 left L12 no 16/15/16 16/14/16 32/29/32 31/20/32 −32 −2 56 e 3
11 right R23 yes 16/15/16 16/16/16 31/29/32 32/32/32 38 2 58 e 4
12 left L01 yes 14/15/16 15/14/16 - - −20 −8 36 b
12 right R12 no 15/14/16 15/14/16 - - 48 −28 58 b
13 left L01 yes 16/23/24 12/14/16 1/15/16 12/15/16 −26 −8 36
13 right R12 no 13/10/24 15/9/24 12/15/15 14/15/16 38 −32 46
14 left L23 yes −/16/16 −/16/16 −/16/16 −/16/16 −54 −18 48 d, e5
14 right R12 no −/16/16 −/15/16 −/16/16 −/16/16 14 −32 72 d
15 left L12 yes 13/15/15 16/16/16 - - −20 −18 48 c
15 right R23 no 15/16/16 16/14/16 - - 40 −36 46 c
16 left L23 yes 16/16/16 16/16/16 16/16/16 14/15/16 −26 −10 34
16 right R23 no 16/15/16 16/15/16 13/16/16 9/15/16 42 −6 56
17 left L01 yes −/15/16 −/14/16 −/16/16 −/16/16 −20 −14 50 d
17 right R01 no 16/15/16 16/16/16 16/16/16 14/16/16 44 −12 58
a

Recording performed ON drug only.

b

Recording performed OFF drug only.

c

ON drug recording excluded from analysis due to very strong wide-band reactivity in M1 (see Methods)

d

M1 recording excluded from analysis due to high frequency responses present in the average (see Methods)

e

Distinct 60-90 Hz peak in drug effect on coherence (see also Figure 7)..

1

Individual frequency window 65-85 Hz, peak coherence: −20 44 2

2

Individual frequency window 65-90 Hz, peak coherence: 46 40 −12

3

Individual frequency window 65-85 Hz, peak coherence: −30 −4 64

4

Individual frequency window 65-80 Hz, peak coherence: 22 6 78

5

Individual frequency window 55-75 Hz, peak coherence: −30 −6 64

f

Distinct 300-400 Hz peak in STN power